Relief Therapeutics Holding AG operates as a biopharmaceutical firm, dedicated to providing vital therapeutic relief to patients suffering from severe diseases for which current medical solutions are insufficient. The company's reach extends across Switzerland, the broader European continent, North America, and various international markets. Its strategic focus is on advancing clinical-stage programs that leverage molecules with a proven history of clinical application.